amoxapine has been researched along with Central Nervous System Disease in 2 studies
Amoxapine: The N-demethylated derivative of the antipsychotic agent LOXAPINE that works by blocking the reuptake of norepinephrine, serotonin, or both; it also blocks dopamine receptors. Amoxapine is used for the treatment of depression.
amoxapine : A dibenzooxazepine compound having a chloro substituent at the 2-position and a piperazin-1-yl group at the 11-position.
Excerpt | Relevance | Reference |
---|---|---|
"Seizures were more common in the amoxapine (24." | 1.27 | Relative toxicity of cyclic antidepressants. ( Gorman, RL; Klein-Schwartz, W; Oderda, GM; Wedin, GP, 1986) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 2 (100.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Kulig, K | 1 |
Rumack, BH | 1 |
Marx, JA | 1 |
Wedin, GP | 1 |
Oderda, GM | 1 |
Klein-Schwartz, W | 1 |
Gorman, RL | 1 |
2 other studies available for amoxapine and Central Nervous System Disease
Article | Year |
---|---|
Amoxapine and neurologic deficits.
Topics: Amoxapine; Central Nervous System Diseases; Dibenzoxazepines; Humans | 1982 |
Relative toxicity of cyclic antidepressants.
Topics: Adolescent; Adult; Aged; Amoxapine; Anthracenes; Antidepressive Agents, Tricyclic; Arrhythmias, Card | 1986 |